 |
|
Outpatient Treatment of Community-Acquired Pneumonia in Adults
Paul V. Pomilla, MD;
Richard B. Brown, MD
Arch Intern Med. 1994;154(16):1793-1802.
Abstract
Most adults with community-acquired pneumonia are treated as outpatients. Despite this, the majority of studies regarding community-acquired pneumonia have been in hospitalized patients only and may not be applicable to an ambulatory population. This review critically examines the literature regarding the diagnosis, cause, appropriate patient selection, and treatment of nonhospitalized adults with community-acquired pneumonia, including human immunodeficiency virus-infected individuals. Englishlanguage articles on oral antibiotic trials for community-acquired pneumonia, obtained from a MEDLINE search from 1966 to the present, are reviewed. Etiologic diagnosis is helpful in determining appropriate outpatient treatment for community-acquired pneumonia, and usually requires only sputum Gram's stain analysis. Viral, mycoplasmal, and chlamydial agents are among the most common pathogens encountered in individuals treated as outpatients, although much variability exists. Many oral antibiotic trials for community-acquired pneumonia have been published, but shortcomings in study design limit their clinical applicability. A treatment algorithm is offered, using the best available data.
(Arch Intern Med. 1994;154:1793-1802)
Author Affiliations
From the Infectious Disease Division, Baystate Medical Center, Springfield, Mass, and the Tufts University School of Medicine, Boston, Mass.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community-Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria
Roson et al.
Clinical Infectious Diseases 2001;33:158-165.
ABSTRACT
| FULL TEXT
Use of a treatment protocol in the management of community-acquired lower respiratory tract infection
Al-Eidan et al.
J Antimicrob Chemother 2000;45:387-394.
ABSTRACT
| FULL TEXT
Doxycycline Revisited
Joshi and Miller
Arch Intern Med 1997;157:1421-1428.
ABSTRACT
|
